Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systems pharmacogenomics in yeast.

Patrick Cahan1, Sharon Marsh, Howard L McLeod

  • 1Washington University School of Medicine, Department of Medicine, Division of Oncology, Computational Biology Program, St Louis, Missouri 63110, USA. pcahan@wustl.edu

Pharmacogenomics
|March 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of parsimonious and temporally sensitive sets of cell fate engineering transcription factors with IMCell.

bioRxiv : the preprint server for biology·2026
Same author

Signaling and transcriptional networks governing late synovial joint development.

Developmental biology·2026
Same author

VIDEO - Visual Integration of Drosophila Enhancer Organization: A tool for integrating and visualizing chromatin accessibility, in vivo transcription factor binding and motif occurrence in tissue-specific differentially expressed genes.

Genetics·2026
Same author

Integrating Somatic and Germline Pharmacogenomics for Therapeutic Decisions in Precision Oncology.

JCO precision oncology·2026
Same author

Protocol to investigate the effects of localized gene expression disruption on mouse limb development via direct siRNA injection and explant culture.

STAR protocols·2026
Same author

TGF-β-induced fibrotic scar formation limits recovery of spinal cord injury.

Bone research·2026
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

This study screened yeast deletion strains against DNA-damaging anticancer agents to identify genes involved in DNA repair pathways. The research uncovered known and novel genes critical for cellular resistance to DNA damage.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Cellular responses to DNA-damaging agents are complex and not fully understood.
  • Mechanistic and therapeutic differences in these responses remain a key research area.

Purpose of the Study:

  • To systematically identify genes involved in DNA damage response pathways.
  • To expand the understanding of cellular resistance mechanisms to various DNA-damaging agents.

Main Methods:

  • Utilized a genome-wide screen of approximately 4700 homozygous deletion strains of Saccharomyces cerevisiae.
  • Assayed the effects of 12 distinct DNA-damaging anticancer agents on yeast survival.

Main Results:

  • Identified genes previously known to be involved in DNA repair.

Related Experiment Videos

  • Discovered novel genes with previously uncharacterized roles in DNA-damage-response pathways.

    • Conclusions:

    • This comprehensive screen provides a valuable resource for understanding DNA damage response.
    • The identified genes offer new targets for cancer therapy and DNA repair research.